pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Larotid
drug
save

amoxicillin

Marketedupdated 3mo ago
by NeoPharma Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval112 co-mentions · 34 sources
  • drugVOQUEZNA DUAL PAK111 co-mentions · 39 sources
  • drugVOQUEZNA TRIPLE PAK111 co-mentions · 39 sources
  • drugLarotid105 co-mentions · 39 sources
  • drugAMOXICILLIN AND CLAVULANATE POTASSIUM105 co-mentions · 39 sources
  • tagSmall Molecule57 co-mentions · 35 sources
  • companySandoz Inc14 co-mentions · 7 sources
  • companyAurobindo Pharma Ltd12 co-mentions · 6 sources

all catalysts(15)

approval · 13
Aug 13, 2007
approval
19y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Dec 20, 2011
approval
15y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Jan 30, 2012
approval
15y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Oct 29, 2014
approval
12y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Feb 9, 2015
approval
12y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Jan 27, 2020
approval
7y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Oct 23, 2023
approval
3y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Apr 25, 2024
approval
2y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Apr 25, 2024
approval
2y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
May 1, 2024
approval
2y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Jun 24, 2024
approval
2y ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Jan 5, 2026
approval
7mo ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Feb 15, 2026
approval
6mo ago
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
phase 2 completion · 2
Apr 30, 2026
phase 2 completion
4mo ago
Qinghai Provincial Xining Third People's Hospital — amoxicillin (Phase II Trial Completion)
amoxicillin
→
Apr 30, 2026
phase 2 completion
4mo ago
Nanjing First Hospital — amoxicillin (Phase II Trial Completion)
amoxicillin
→
view all 15 catalysts →

Trials studying amoxicillin

  • N/ACholine to Improve Malnutrition and Enhance Cognitionactive not recruitingn=1,500
  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • phase2Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trialnot yet recruitingn=300
  • phase1Drug Interaction Study on Linaprazan Glurate Capsulescompletedn=56
  • phase3Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pyloricompletedn=461
  • phase4Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))recruitingn=120
  • phase3Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infectioncompletedn=700
  • phase1A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infectioncompletedn=39
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Dec 8, 2026
115 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

  • May 7, 2027method-of-use (U-1304)US 8299052265d
  • Dec 8, 2026formulationUS 8357394115d
  • Dec 8, 2026compositionUS 8778924115d

News(0)

no news has mentioned this drug yet

brand
Larotid
generic
amoxicillin
indication
Gonorrhea
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 28m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?